PharmaLegacy Laboratories (Shanghai) Co., Ltd is a professional supplier which provides a variety of PDX Model, to provide customers withGood after-sales servicePDX Model ,PDX Modeland PDX Model and so on. Since the company had been established in Building 7, 388 Jialilue Road Zhangjiang High-Tech Park Pudong District Shanghai,Pudongxin District,City area,Shanghai,China, adhere to people-oriented ,and the quality of survival, to the credibility of development,our company have made an outstanding achievement.

   

The advantage of PharmaLegacyPDX Modelx2a38631nis that it can provide more professional and thoughtful solutions timely and accurately according to the actual needs of customers.At the same time, Our company follow the latest developments on Business services,Medical service,Medical insurance, and establish long and steady partnership relation with many well-known enterprises in the same industry , to provide customers with the most professional, advanced Respiratory Disease Model.Details:Patient-derived tumor xenograft mouse models (PDX Model) are a versatile oncology research platform for studying tumor biology and for testing chemotherapeutic approaches tailored to genomic characteristics of individual patient's tumors. PDX models are typically implanted as dissociated cells or tumor fragments into immune-deficient mouse models which may then be used for in vivo efficacy studies, allowing you to accelerate your oncology research or drug discovery and development programs. PDX models are generated and distributed by a diverse group of academic labs, research organizations, multi-institution consortia, and contract research organizations. To better preserve the genomic integrity and tumor heterogeneity observed in patients, patient-derived xenograft (PDX) models were generated using freshly resected patient tumors immediately transplanted into immunocompromised murine hosts without an intermediate in vitro culture step. Pharmalegacy has patient information with diagnosis and treatment history, with 367 PDX models covering 6 cancer types and more ongoing. Pharmalegacy has well established PDX model and ready for cancer therapeutics evaluation.

   PharmaLegacy always adheres to the corporate purpose: Sincere service, the pursuit of perfectionand advancing with the times,make progress together with51-100 people people, and go hand in hand to get innovation and a win-win situation. To get more information about PDX Model,, you can log in and look through PharmaLegacy official website:www.pharmalegacy.com

PharmaLegacy Laboratories is a leading speciality pharmacology Contract Research Organization located in Shanghai Zhangjiang High-Tech Park, China. PharmaLegacy is equipped with a world-class facility, working to international pharmaceutical industrial standards. PharmaLegacy provides preclinical in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program. Our state-of-the-art platforms include:· Pioneering work using CD34+ humanized mice that carry a human immune system, to test biologics for immuno-oncology therapeutic efficacy· An NHP platform for therapeutic biologics testing in a variety of immune diseases · An advanced antibody discovery platform based on single B cell antibody sequencing · An internationally recognized Bone/Orthopaedics platform to test both hard tissue disease therapeutic candidates and medical devicesPharmaLegacy offers a full range of preclinical pharmacology services for evaluating pharmacological effects of drug candidates in the areas of inflammation/auto-Immune diseases, lung injury, liver/metabolic diseases and oncology. Our NHP platform and CD34+ humanized mice models have helped dozens of clients with IND filings